WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555217

CAS#: 173528-92-2

Description: HMN-154 is a benzenesulfonamide anticancer agent. HMN-154 inhibits DNA binding of NF-Y to the human major histocompatibility complex class II human leukocyte antigen DRA Y-box sequence in a dose-dependent manner.

Price and Availability

Size Price Shipping out time Quantity
100mg USD 950 2 Weeks
200mg USD 1450 2 Weeks
500mg USD 1950 2 Weeks
1g USD 2950 2 Weeks
2g USD 4650 2 Weeks
5g USD 7250 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2021-01-20. Prices are subject to change without notice.

HMN-154, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 555217
Name: HMN-154
CAS#: 173528-92-2
Chemical Formula: C20H18N2O3S
Exact Mass: 366.1038
Molecular Weight: 366.435
Elemental Analysis: C, 65.56; H, 4.95; N, 7.65; O, 13.10; S, 8.75

Synonym: HMN-154; HMN 154; HMN154.

IUPAC/Chemical Name: (E)-4-(2-(2-(N-(4-Methoxybenzenesulfonyl)amino)phenyl)ethenyl)pyridine


InChi Code: InChI=1S/C20H18N2O3S/c1-25-18-8-10-19(11-9-18)26(23,24)22-20-5-3-2-4-17(20)7-6-16-12-14-21-15-13-16/h2-15,22H,1H3/b7-6+


Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1: Tanaka H, Ohshima N, Hidaka H. Isolation of cDNAs encoding cellular
drug-binding proteins using a novel expression cloning procedure: drug-western.
Mol Pharmacol. 1999 Feb;55(2):356-63. PubMed PMID: 9927629.